The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.


Updates from The Motley Fool

Latest updates on Acadia Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Acadia Pharmaceuticals.


Stock Performance

View Interactive ACAD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Acadia Pharmaceuticals.
Current Price: $28.98
Prev Close: $28.97
Open: $29.18
Bid: $28.68
Ask: $29.10
Day's Range: $28.85 - $29.57
52wk Range: $24.82 - $41.20
Volume: 1,642,487
Avg Vol 1,725,081
Market Cap: $4B
P/E (ttm): -11.78
EPS (ttm): ($2.46)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Acadia Pharmaceuticals.
CAPS Rating 2 out of 5
 
302 Outperform
75 Underperform
CAPS All Stars
 
52 Outperform
20 Underperform

How do you think Acadia Pharmaceuticals will perform against the market?



You pick for Acadia Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Steve Davis, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Acadia Pharmaceuticals.

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers